• Call +1.858.633.0165 or Fax +1.858.633.0166 or Contact Us

VEGF-C152S Rat Active Protein

For Research Use Only. Not for use in diagnostic procedures. Catalog #: MBS692062

VEGF-C152S is a point mutant generated by the replacement of the second conserved Cys residue of the recombinant processed VEGF-C by a Ser residue. VEGF-C152S is analog to the human VEGF-C156S mutant and only active toward VEGFR-3/FLT-4 but, unlike wild type… More details

$295 / 0.005 mg +1 FREE 8GB USB
Product Documentation
PDF
Sample Manual Insert View PDF
PDF
Testing Data View PDF
PDF
Certificate of Analysis (COA) View PDF
PDF
QC Report View PDF
PDF
Material Safety Data Sheet View PDF
PDF
Technical Datasheet View PDF
PDF
Protocol View PDF

Product Overview

Online Datasheet in PDF
Product Name
VEGF-C152S, Active Protein
Full Product Name
Rat VEGF-C152S
Product Gene Name
Product Synonym Names
Vascular Endothelial Growth Factor C; VEGFC
Sequence
DTVKLAAAHY NTEILKSIDN EWRKTQCMPR EVCIDVGKEF GAATNTFFKP PSVSVYRCGG CCNSEGLQCM NTSTGYLSKT LFEITVPLSQ GPKPVTISFA NHTSCRCMSK LDVYRQVHSI IHHHHHH
Host
Insect Cells
Species Reactivity
Rat
Form/Format
Lyophilized
Purity/Purification
> 90% by SDS-PAGE & silver stain
Preparation and Storage
Lyophilized samples are stable for greater than six months at -20 degree C to -70 degree C. Reconstituted VEGF-C152S should be stored in working aliquots at -20 degree C. Avoid repeated freeze-thaw cycles!
Molecular Weight
18-24 kDa
Chromosome Location
Chromosome: 16; NC_005115.3 (40216307..40331753, complement). Location: 16p11
3D Structure
ModBase 3D Structure for P15692
Active Protein Note
Protein activity can be an ambiguous term. Please refer to the data sheet or inquire with Technical Support to determine the definition of activity for this product.
Buffer
50 mM acetic acid
Stabilizer
BSA
Reconstitution
Centrifuge the vial prior to opening! The lyophilized VEGF-C152S should be reconstituted in PBS or medium to a concentration not lower than 50 ug/ml.
Biological Activity
(A) The proliferative response to rrVEGF-CC152S was assayed in VEGFR3-expressing porcine aortic endothelial (PAE) cells (in vitro). (B) The lymphangiogenic response to rrVEGF-CC152S loaded in a biopolymeric albumin-alginate microcapsules for targeted slow-release was assayed in male Wistar rats.
Protein RefSeq
NP_446105.1
mRNA RefSeq:
NM_053653.1
ISO Certification
Manufactured in an ISO 9001:2008 Certified Laboratory.

SDS-PAGE of VEGF-C152S active protein

SDS-PAGE analysis of recombinant rat VEGF-C152 mutant. Sample was loaded in 15% SDS-polyacrylamide gel under reducing conditions and stained with Coomassie blue.
Rat VEGF-C152S Active Protein – Cat# MBS692062

Testing Data of VEGF-C152S active protein

In vivo: The lymphangiogenic response to recombinant rat VEGFCC152S loaded in our biopolymeric albumin-alginate microcapsules for targeted slow-release was assayed in male Wistar rats. Briefly, after ischemiareperfusion injury to induce myocardial infarction, VEGF-CC152S at the dose of 1.5 or 5 ug per heart was injected intra-myocardially. Lymphatic responses in the myocardium were analyzed by IHC at 3 weeks post-MI using LYVE1 antibody. Results are expressed as lymphatic vessel to cardiomyocyte ratio (mean + sem).
The experiments were performed by the research group of Prof. Dr. E. Brakenhielm – Rouen University (see also: Henri O et al., Circulation, March 2016, DOI: 10.1161)
Rat VEGF-C152S Active Protein, Testing Data – Cat# MBS692062

Testing Data of VEGF-C152S active protein

In vitro: The proliferative response to recombinant rat VEGF-CC152S was assayed in VEGFR3-expressing porcine aortic endothelial (PAE) cells. Briefly, cells were plated in 12-well plates and incubated in DMEM medium supplemented with 1% fetal calf serum for cell cycle arrest 24h prior to stimulation of cell proliferation with recombinant VEGF-CC152S at the concentrations of 50 and 100 ng/mL. After 48h in culture, the cell proliferative response was assayed (WST-1 colorimetric assay), and the results expressed as % of control non-stimulated cells (mean + sem).
Rat VEGF-C152S Active Protein, Testing Data – Cat# MBS692062

Product References and Citations for VEGF-C152S active protein

1. Joukov et al., J Biol Chem 273 :6599, 1998 2. Joukov et al., EMBO J 15:290, 1996 3. Olofsson et al., Curr Opin Biotech 10:528, 1999 4.Kirkin et al., Eur J Biochem 268:5530, 2001

Other Notes

Small volumes of VEGF-C152S active protein vial(s) may occasionally become entrapped in the seal of the product vial during shipment and storage. If necessary, briefly centrifuge the vial on a tabletop centrifuge to dislodge any liquid in the container`s cap. Certain products may require to ship with dry ice and additional dry ice fee may apply.

Searchable Terms for VEGF-C152S purchase

MBS692062 is an active protein targeting VEGF-C152S. Also known as Rat VEGF-C152S. Reactive in Rat. Host: Insect Cells.

Additional Details

NCBI/Uniprot data below describe general gene information for VEGF-C152S. It may not necessarily be applicable to this product.

NCBI GI #
NCBI GeneID
NCBI Accession #
UniProt Primary Accession #
UniProt Secondary Accession #
UniProt Related Accession #
GenBank Nucleotide #
NCBI Official Full Name
vascular endothelial growth factor C
NCBI Official Synonym Full Names
vascular endothelial growth factor C
NCBI Official Symbol
Vegfc
UniProt Protein Name
Vascular endothelial growth factor C
UniProt Synonym Protein Names
Flt4 ligand; Flt4-L; Vascular endothelial growth factor-related protein
UniProt Gene Name
Vegfc
UniProt Synonym Gene Names
VEGF-C; Flt4-L; VRP
UniProt Entry Name
VEGFC_RAT
NCBI Protein Information
vascular endothelial growth factor C; VRP; VEGF-C; flt4-L; flt4 ligand; vascular endothelial growth factor-related protein

NCBI Summary for VEGF-C152S

platelet-derived growth factor/vascular derived growth factor (PDGF/VEGF); active in angiogenesis and endothelial cell growth [RGD, Feb 2006]

UniProt Comments for VEGF-C152S

Function: Growth factor active in angiogenesis, and endothelial cell growth, stimulating their proliferation and migration and also has effects on the permeability of blood vessels. May function in angiogenesis of the venous and lymphatic vascular systems during embryogenesis, and also in the maintenance of differentiated lymphatic endothelium in adults. Binds and activates VEGFR-2 (KDR/FLK1) and VEGFR-3 (FLT4) receptors.

Subunit structure: Homodimer; non-covalent and antiparallel.

Subcellular location: Secreted.

Tissue specificity: Highly expressed in the lung, ovary, preputial gland and the adrenal gland. Expressed in the post-pubertal mammary glands. Ref.1 Ref.2

Developmental stage: Increases moderately during pregnancy (2.8-fold increase on day 4) and lactation (1.9-fold increase on day 2). Ref.2

Post-translational modification: Undergoes a complex proteolytic maturation which generates a variety of processed secreted forms with increased activity toward VEGFR-3, but only the fully processed form could activate VEGFR-2. VEGF-C first form an antiparallel homodimer linked by disulfide bonds. Before secretion, a cleavage occurs between Arg-223 and Ser-224 producing a heterotetramer. The next extracellular step of the processing removes the N-terminal propeptide. Finally the mature VEGF-C is composed mostly of two VEGF homology domains (VHDs) bound by non-covalent interactions

By similarity.

Miscellaneous: Indolinones; MAE87, MAE106 and MAZ51 inhibit VEGF-C induced activation of VEGFR-3.

Sequence similarities: Belongs to the PDGF/VEGF growth factor family.
Show more

Precautions

All of MyBioSource's Products are for scientific laboratory research purposes and are not for diagnostic, therapeutics, prophylactic or in vivo use. Through your purchase, you expressly represent and warrant to MyBioSource that you will properly test and use any Products purchased from MyBioSource in accordance with industry standards. MyBioSource and its authorized distributors reserve the right to refuse to process any order where we reasonably believe that the intended use will fall outside of our acceptable guidelines.

Disclaimer

While every efforts were made to ensure the accuracy of the information provided in this datasheet, MyBioSource will not be liable for any omissions or errors contained herein. MyBioSource reserves the right to make changes to this datasheet at any time without prior notice.

It is the responsibility of the customer to report product performance issues to MyBioSource within 30 days of receipt of the product. Please visit our Terms & Conditions page for more information.

Product Note

Select online data sheet information is drawn from bioinformatics databases, occasionally resulting in ambiguous or non-relevant product information. It is the responsibility of the customer to review, verify, and evaluate the information to make sure it matches their requirements before purchasing the kit. Our ELISA Kit assays are dynamic research tools and sometimes they may be updated and improved. If the format of this assay is important to you then please request the current manual or contact our technical support team with a presales inquiry before placing an order. We will confirm the current details of the assay. We cannot guarantee the sample manual posted online is the most current manual, it is intended to serve as an example only. Please refer to the instructions For Use provided with the assay kit for precise details.

Product PubMed Publications

Request a Quote

Please fill out the form below and our representative will get back to you shortly.

MBS000000
Contact Us

Please fill out the form below and our representative will get back to you shortly.

MBS000000